Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review (Q33726705)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review |
scientific article |
Statements
1 reference
Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review (English)
1 reference
1 reference
Yoon K Loke
1 reference
Gerd Antes
1 reference
Monika Lelgemann
1 reference
Hansjuergen T Agostini
1 reference
Christoph Ehlken
1 reference
Lutz L Hansen
1 reference
22 October 2010
1 reference
1 reference
Identifiers
1 reference